Back
Karyopharm Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
KPTI
Karyopharm Therapeutics
Last Price:
0.85
Seasonality Move:
-2.8%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KPTI is experiencing slight buying pressure.
Karyopharm Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.82 | Sell |
| 20-day SMA: | 0.86 | Sell |
| 50-day SMA: | 0.82 | Sell |
| 200-day SMA: | 1.02 | Sell |
| 8-day EMA: | 0.81 | Sell |
| 20-day EMA: | 0.84 | Sell |
| 50-day EMA: | 0.84 | Sell |
| 200-day EMA: | 1.01 | Sell |
Karyopharm Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 41.33 | Sell |
| Chaikin Money Flow: | -20521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.81 - 0.91) | Sell |
| Bollinger Bands (100): | (0.76 - 0.92) | Sell |
Karyopharm Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karyopharm Therapeutics Stock
Is Karyopharm Therapeutics Stock a Buy?
- Karyopharm Therapeutics share price is 0.78 while KPTI 8-day simple moving average is 0.82, which is a Sell signal.
- The stock price of KPTI is 0.78 while Karyopharm Therapeutics 20-day SMA is 0.86, which makes it a Sell.
- Karyopharm Therapeutics 50-day simple moving average is 0.82 while KPTI share price is 0.78, making it a Sell technically.
- KPTI stock price is 0.78 and Karyopharm Therapeutics 200-day simple moving average is 1.02, creating a Sell signal.
KPTI Technical Analysis vs Fundamental Analysis
Sell
28
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy or a Sell?
-
Karyopharm Therapeutics stock is rated a Sell
The current Karyopharm Therapeutics [KPTI] share price is $0.78. The Score for KPTI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Karyopharm Therapeutics Stock Info
Market Cap:
97.44M
Price in USD:
0.78
Share Volume:
278.5K
Karyopharm Therapeutics 52-Week Range
52-Week High:
1.95
52-Week Low:
0.62
Sell
28
Karyopharm Therapeutics (KPTI)
is a Sell
Karyopharm Therapeutics Share Price Forecast
-
What is the Karyopharm Therapeutics stock price today?
The Karyopharm Therapeutics stock price is 0.78 USD today. -
Will KPTI stock go up or go down?
Karyopharm Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Karyopharm Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karyopharm Therapeutics is overvalued.
Is Karyopharm Therapeutics Stock a Buy?
- Karyopharm Therapeutics share price is 0.78 while KPTI 8-day exponential moving average is 0.81, which is a Sell signal.
- The stock price of KPTI is 0.78 while Karyopharm Therapeutics 20-day EMA is 0.84, which makes it a Sell.
- Karyopharm Therapeutics 50-day exponential moving average is 0.84 while KPTI share price is 0.78, making it a Sell technically.
- KPTI stock price is 0.78 and Karyopharm Therapeutics 200-day simple moving average is 1.01, creating a Sell signal.
Fundamental Analysis of Karyopharm Therapeutics
Is Karyopharm Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Karyopharm Therapeutics
Should I short Karyopharm Therapeutics stock?
- KPTI Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Karyopharm Therapeutics is a Sell
- Karyopharm Therapeutics Relative Strength Index (RSI) is 41.33, which suggest Karyopharm Therapeutics is oversold
- The Bollinger Bands (25) for Karyopharm Therapeutics is (0.81 - 0.91), which suggest Karyopharm Therapeutics is a Sell
- The Bollinger Bands (100) for Karyopharm Therapeutics is (0.76 - 0.92), which suggest Karyopharm Therapeutics is a Sell
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.